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Abstract
Background: Despite increasing governmental anti-smoking measures, smoking prevalence remains at a high level
in France.
Methods: The objectives of this panel study were (1) to estimate smoking prevalence in France, (2) to identify
smokers’ profiles according to their perceptions, attitudes and behaviour in relation to smoking cessation, (3) to
determine predictive factors of quit attempts, and (4) to assess tobacco-related behaviours and their evolutions
according to the changes in the smokers’ environments. A representative sample of French population was
defined using the quota method. The identified cohort of smokers was assessed, in terms of smoking behaviour,
previous quit attempts, and intention to quit smoking.
Results: A response rate of 66% for the screening enabled to identify a representative sample of the French
population (N = 3 889) comprising 809 current smokers (21%). A majority of current smokers (63%) had made an
attempt to quit smoking. Main reasons for having made the last attempt were cost (44%), social pressure (39%), wish
to improve physical fitness (36%), fear of a future smoking-related disease (24%), and weariness of smoking (21%).
Few attempts (16%) were encouraged by a physician. In those who used some kind of support (38%), NRT was the
mostly used. Relapse was triggered by craving (45%), anxiety/stress (34%), a significant life event (21), weight gain
(18%), and irritability (16%). Depression was rarely quoted (5%). Forty percent of smokers declared they intended to
quit smoking permanently. Main reasons were cost (65%), physical fitness improvement (53%), fear of a future
smoking-related disease (43%), weariness of tobacco (34%), and social pressure (30%). Using a smoking cessation
treatment was considered by 43% of smokers that intended to quit. Barriers to smoking cessation were mainly fear of
increased stress (62%), irritability (51%), and anxiety (42%), enjoying smoking (41%), and weight concerns (33%).
Conclusion: Smoking prevalence and smoking cessation attempts rate were lower in this survey than in previous
reports. Cost and social pressure were the main reasons for quitting smoking, maybe an effect of dramatic tax
increases and smoking ban.
Background
Total tobacco-attributable deaths are projected to rise
from 5.4 million in 2005 to 6.4 million in 2015 and 8.3
million in 2030, being responsible for 10% of all deaths
globally[1]. Populationwide-interventions that can
reduce smoking prevalence are important for curbing
the pandemic of tobacco-related disease. Different mod-
alities provide evidence of effectiveness [2]: educational
strategies, regulation of advertising and promotion,
clean air regulations and restriction of minors’ access to
tobacco products, taxation on tobacco products, and
treatment of nicotine addiction. In a recent comparison
of 36 countries for tobacco dependence treatment
* Correspondence: henri-jean.aubin@pbr.aphp.fr
1Hôpital Paul Brousse (AP-HP), Villejuif, France, Hôpital Emile Roux(AP-HP),
Limeil-Brévannes, INSEM U699, France
Aubin et al. BMC Public Health 2010, 10:100
http://www.biomedcentral.com/1471-2458/10/100
© 2010 Aubin et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.services, France ranked third on a tobacco control scale,
behind England and Scotland [3]. This encouraging
score was based on the existence of an official treatment
policy, an officially identified person managing treat-
ment service, a national quitline, a specialized and easily
available treatment system with a network of tobacco
treatment specialists[4], medications availability, and a
package reimbursement.
In France, tobacco use is estimated to cause every year
about 60,000 premature deaths [5,6]. Smoking preva-
lence is estimated to be 29.9% [6], 31% [7], or 34.2% [8],
depending on the survey. The ITC Four-Country survey
has shown that at least 36% of smokers make a quit
attempt in a given year [9]. Even though one can antici-
pate similar numbers in France, we haven’tf o u n ds p o n -
taneous quitting attempt rates from French reports.
Tobacco control has become a priority for the French
government, who strengthened its anti-tobacco policy in
the early 2000s[7]. Cigarette taxes have dramatically
increased in 2003, and again in 2004. The leading smok-
ing cessation drugs have been made available in France:
nicotine replacement therapy (1985), bupropion (2001),
and varenicline (2007). The reported survey took place a
few months before the implementation of several conco-
mitant changes in tobacco control in France, all in Feb-
ruary 2007: the smoking ban in public indoors, a
financial support of up to 50 Euros a year per quitter by
National Health Services, and the launch of the new
smoking cessation drug Varenicline. Little is still known
about smokers’ behaviours in reaction to all these
measures
The objectives of this population-based epidemiologi-
cal panel study were:
￿ To estimate smoking prevalence in France;
￿ To identify smokers’ profiles according to their
perceptions, attitudes and behaviour in relation to
smoking cessation;
￿ To determine predictive factors of quit attempts;
￿ To assess tobacco-related behaviours and their
evolutions according to the changes in the smokers’
environments.
This paper will present the study methodology and the
main results obtained in the recruitment phase.
Methods
This study has been carried out by the Market Research
Company TNS Healthcare Sofres. Although no nomina-
tive data were recorded, the study was notified to the
French personal data surveillance authorities (Commis-
sion Nationale Informatique et Libertés) and was con-
ducted according to the relevant national and European
laws and consensus professional guidelines. Subjects
enrolled into the study were informed of the objectives
of the study, the nature of transmitted data and their
use, and their right to refuse.
Study design
This survey is to be performed in five waves, several
months apart, for a total follow up of 24 months. The
study design is shown in Figure 1.
Wave 1 consisted in screening to select a national
representative sample of smokers. A self-administered
questionnaire was sent by mail to a national representa-
tive sample of 6,032 subjects aged 15 years or more
from September 28th to November 13th 2006.
The four further waves were performed by phone
(CATI system - Computer Assisted Telephone Inter-
viewing). Data collection was performed by means of a
questionnaire presented by TNS Sofres research inter-
viewers. Smokers identified in Wave 1-screening were
called in June 2007 (Wave 2), then in November 2007
(Wave 3), June 2008 (Wave 4), and finally November
2008 (Wave 5).
Subjects
The screening was conducted among the ACCESS
SANTE permanent polling base, representative of the
French population. Its representativeness and algorithms
of sample selection are permanently verified by experts
from the Institut National de la Statistique et des Etudes
Economiques (INSEE) and EUROSTAT, and regular
audits are performed. Individuals entered in this base
are recruited in several ways (face-to-face interviews,
phone calls or mailings), thus reducing the possible risk
of selection bias which could be associated with a parti-
cular methodology. Panellists participate in six to eight
health surveys in a year and receive incentive services in
return for their participation (no payment). The overall
response rate is 70-75% for health surveys.
A self-administered questionnaire was mailed to a
selected representative sample of 6,032 panellists aged
15 years and more, by using the quota method.
Survey questionnaire
Apart from socio-demographic information, the screen-
ing questionnaire comprised 35 questions. The first
question was aimed at establishing the smoking status:
current smoker, ex-smoker, or never-smoker. For all
participants, sociodemographics, risk factors and comor-
bidities were explored. For working subjects, distinction
was made between high and low qualification.
For current smokers, questions were asked on smok-
ing habits: daily or occasional use, number of daily
cigarettes, duration of smoking, and age of first cigar-
ette. The following conversion was established for non
cigarette tobacco products: 1 cigarillo = 2 cigarettes; 1
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Page 2 of 86 032 letters sent to a national representative sample of 
subjects aged 15 years and more 
(September to November 2006)
3 932 questionnaires returned (66%) 
3 889 completed and analysed
NON smokers 
Ex-smokers (n = 999)  
or never smoked (n = 2081) 
Current smokers 
n = 809 (21 %) 
Survey Wave 2 
June 2007 
Survey Wave 3 
November 2007 
Survey Wave 4 
June 2008 
Survey Wave 5 
November 2008
Figure 1 Study Design.
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dependence was evaluated by Fagerström Test for Nico-
tine Dependence (FTND)[10].
Information was collected on any attempt to quit
smoking: number of attempts and time of first attempt.
The last attempt was more thoroughly described: dura-
tion, role of health professionals, reasons which trig-
gered the attempt, treatments used.
Last, the intention for a future smoking cessation was
explored: any contemplation of smoking cessation, esti-
mated timeline to attempted cessation, reasons for stop-
ping, planned smoking cessation treatments, and factors
which would influence the decision to stop. An adapta-
tion of the “Barriers to smoking cessation checklist” was
used [11].
Initially, the self-administered questionnaire had been
tested on 8 smokers by means of face-to-face interviews
in order to ensure a good comprehension.
Statistical analysis
The representativeness of the sample was assessed by
using the quota method[12], and computerised weight-
ing was used, according to the Ranking Adjusted Statis-
tics method [13], In order to reduce the bias due to non
respondents to the screening mail, sociodemographic
characteristics of the respondents were adjusted to the
structure of the French general population aged 15 years
and more [14]. Computerised weighting was therefore
used on five criteria: gender (2 categories), age (5 cate-
gories), socioprofessional status (8 categories), region (9
categories), and community size (5 categories). Weight-
ing the sample ensured it was still representative of the
national population. The underlying reason is that only
a sample with the same structure as the mother popula-
tion on defined criteria allows generalising the answers
brought to other criteria to the total population. A
descriptive analysis was performed for each wave. All
analyses were conducted using SAS software, version 8.0
(SAS Institute).
Results
Out of 6,032 sent questionnaires, 3,932 were returned, i.
e. the response rate was 66%. Of these, 43 (1%) were
excluded because they were returned incomplete, and
3,889 were kept for analysis. As older and retired people
were over-represented, weighting was comprised
between 0.4 and 3.4, and its efficacy was 76.5%. After
weighting, the sample of 3 889 individuals aged 15 years
and more, was divided into 809 (21%) current smokers,
999 (26%) ex-smokers, and 2,081 (53%) never-smokers.
Thus, extrapolation to the general population of France
aged 15 years and more showed a smoking prevalence
of 21%, i.e. approximately 10 million individuals. In
order to have a better comparison of our results to a
competing French survey [6,7], we also calculated the
prevalence of smoking after exclusion of subjects over
75 years of age: the prevalence increased up to 22.1%.
Current smokers were predominantly young working
males, with a rather low qualification. They had no
increase of overweight/obesity or risk factor treatment
prevalence compared to ex or never-smokers (Table 1).
Smokers
Ninety percent smoked regularly (at least weekly), of
whom 85% smoked everyday. The vast majority (95%)
were cigarettes smokers, with a mean (SD) consumption
of 14.2 (9.4) cigarettes a day. Median was at 13 cigar-
ettes a day. Adding regular cigars, cigarillos and pipe
smokers, the mean smoking rate reached 14.7 cigarette
equivalents. Mean (SD) FTND score was 3.1 (2,6).
Median score was 3.
In terms of duration, more than half the subjects
(52%) have smoked for over 20 years, with a mean age
of 16.5 years for the first cigarette (range: 5-50 years;
median: 16 years).
A profile of smokers was established according to the
fact they smoked more or less than 13 cigarettes per
day (median taken as a cut off). Smokers above the
median consumption (≥ 13 daily cigarettes) were more
often males (61%), and they started smoking at a
younger age (15.8 vs 17.1 years-p < 0.01), but no differ-
ence was observed in terms of age category, work status
or duration of smoking.
Last attempt of smoking cessation
Sixty three percent of current smokers have made at
l e a s to n ea t t e m p tt os t o ps m o k i n g :2 7 %w i t ho n es i n g l e
attempt and 36% attempted several times. The chance
of having made at least one attempt varied with age
category: 46%, 70%, 64%, 62%, in age 15-24, 25-39, 40-
49, and 50+ categories, respectively. Mean (SD) number
of attempts was 2.2 (1.4) in smokers who made at least
Table 1 Sociodemographics and risk factors in current,
ex, and never-smokers
Current smokers Ex-smokers Never-smokers
N (%) 809 (21%) 999 (26%) 2081 (53%)
Male gender 56% 60% 39%
Age* 40.0 (15.0) 53.4 (16.4) 45.2 (19.9) A
Working 69% 54% 48%
Low qualification 47% 31% 24%
Body Mass Index (BMI)* 24.2 (4.5) 26.1 (4.7) 24.4 (4.5)
BMI ≥ 25 kg/m
2 36% 54% 39%
Treated for a risk factor** 15% 36% 25%
* Mean (SD)
** Risk factors: hypertension, diabetes, hypercholesterolemia
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smoking was significantly more frequent in employed
rather than unemployed smokers (p < .01), and in daily
than non daily smokers (p < .01). The median duration
for the last attempt was 2 months, ranging from less
than 24 hours (7%) to over 1 year (18%), the majority
(56%) lasting 3 months or less.
Overall, 16% of last attempts to quit smoking were
encouraged by a physician. They were mostly general
practitioners (63%), then, far behind, cardiologists (18%)
or gynecologists (14%). Chest physicians were only men-
tioned in 11% of cases, and tobacco treatment specialists
in 9%. The majority of attempts was not encouraged by
anybody in particular (Table 2). Family circles were par-
ticularly active. However the last attempt was mostly
self-initiated.
The main reason for having made the last attempt to
quit smoking was cost, mentioned by 44% of smokers,
followed by social pressure (39%), the wish to improve
physical fitness (36%), fear of a future smoking-related
disease (24%), weariness of smoking (21%), and the exis-
tence of a pulmonary or cardiovascular condition (14%).
Few smokers quoted smoking ban and other anti-smok-
ing laws (4%), the marketing of a new smoking cessation
drug (3%), or information campaigns (2%) as reasons to
having made their last quit attempt.
Only 11% of smokers having made a quit attempt
sought help from a physician when they attempted to
stop smoking: 8% did so for their first and only attempt,
and 13% when they made several attempts. Those who
wished help from a physician mainly chose a general
practitioner (77%); secondly tobacco treatment specia-
lists were consulted (12%). Cardiologists (3%), chest phy-
sicians (2%), and gynecologists (2%) weren’to f t e n
chosen. Mean visits to the physician was 2.2.
Even if support methods were more widely used by
those who made several attempts (41% vs 25% for a first
attempt, p < 0.01), still 62% did not use any support to
quit smoking. Nicotine replacement therapy was mostly
used: nicotine patch (20%), gums (12%), tablets (1%),
and inhaler (1%). Bupropion was used in 5% of attempts.
Other methods such as acupuncture, homeopathy, and
hypnosis were also used as an aid to smoking cessation
by 4% of the subjects.
Amongst the reasons that lead to resumed smoking,
craving was the most frequently mentioned (45%), fol-
lowed by anxiety/stress (34%), significant life event
(21%), weight gain (18%), and irritability (16%). Other
reasons were not reported more than in 5% of cases.
Table 3 displays duration of attempts as a function of
reason for relapse.
Intention to quit smoking
Forty percent of current smokers declared they intended
to stop permanently, more so in those who had pre-
viously made a quit attempt (52% vs 22%, p < .01). Of
these, 5% intended to quit in the following week, 11% in
the following 30 days, 55% in the following 6 months,
24% after 6 months, and 5% didn’t specify. Intention to
quit smoking was more frequent in daily than in non
daily smokers (p < .01), but was unrelated to socio-
demographic variables. Reasons mentioned comprised:
high price of cigarettes (65%), wish to improve physical
fitness (53%), fear of a future smoking-related disease
(43%), weariness of tobacco (34%), social pressure (30%),
and current smoking-related disease (14%). Other rea-
sons mentioned were smoking ban in public places
Table 2 Persons encouraging the last attempt of smoking
cessation.
Single attempt
n = 219
Several attempts
n = 287
Physician (%) 9% 21%
Family circle (%) 35% 44%
Circle of friends (%) 6% 12%
Work colleagues (%) 3% 4%
Pharmacist (%) 1% 3%
Other (%) 1% 1%
Nobody in particular (%) 54% 46%
No answer (%) 4% 3%
Table 3 Duration of attempts as a function of reasons for relapse.
Reason of relapse Frequency of report Mean (SD) duration of attempts (months) Median duration of attempts (months)
Craving 45% 6.7(19.4) .8
Anxiety/stress 34% 9(20.3) 1
Significant life event 21% 19.3(35.4) 6.2
Weight gain 18% 11.5(22.6) 4
Irritability 16% 3.8(9.7) .4
Depression 5% 26.6(36.3) 12
Request of significant others 3% 1.4(1.6) .8
Price of treatment 3% 2.7(2.9) 2
Treatment-emergent adverse events 3% 1.7(2.6) .3
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(7%), the feeling that smoking behavior is marginalizing
(4%), and information campaigns by the media (2%).
Forty-three percent of smokers who intended to quit
definitively reported considering using a smoking cessa-
tion treatment. Nicotine patch was the most quoted
treatment (18%), followed by nicotine gums (10%),
bupropion (9%), varenicline - that was to be marketed
several months after the survey - (5%), nicotine tablets
(2%), and nicotine inhaler (1%). Other methods such as
acupuncture, homeopathy, and hypnosis were quoted by
8% of the subjects.
Barriers to smoking cessation were mainly fear of
increased stress, irritability, and anxiety, enjoying smok-
ing, and weight concerns (table 4).
Discussion
This survey found a surprisingly low smoking prevalence
(21%) in the French population aged 15 or more. Of
these, 85% were daily smokers. Thus, prevalence of daily
smoking was 18%. Mean smoking rate was between 14.2
and 14.7 cigarettes per day, depending on the method
used to convert non cigarette tobacco use. Prevalence of
ex-smoking was 26%. Competing numbers come from
the European survey on tobacco performed in 2008 in a
representative sample of subjects aged 15 or more,
showing a 34.2% smoking prevalence in France, a 28.3%
daily smoking prevalence, and a 22.1% ex-smoking pre-
valence [8]. A French survey performed in 2005 in a
representative sample of subjects aged 12-75 showed a
smoking prevalence of 29.9%, a daily smoking preva-
lence of 24.9%, and an ex-smoking prevalence of 27.3%
[6]. In this survey, mean smoking rate was 14.8 cigar-
ettes per day in daily smokers, comparable to our
results. Finally, a telephone survey performed in 2008
showed a smoking prevalence of 31% [7]. Why we
found a lower smoking prevalence than others is
unclear. To the least, our result suggests previously pub-
lished smoking prevalence numbers [6-8] could be over-
estimated.
Our results also show a lower rate of smoking cessa-
tion attempts (63%) in current smokers than in the 2005
national survey (76.5%) [6]. Yet, only one week success
were taken into account in the 2005 survey, as our
study considered all attempts, even of shorter duration.
Other European surveys have shown smoking cessation
attempts rate exceeding 70% [15]. Few of these attempts
were prompted by physicians. This lack of medical
involvement has been emphasized by others in France
[6] and in other countries [16-19]. In our study, family
circle seemed to have the lead in triggering smoking
attempts, even though about half of the quit attempts
weren’t prompted by a third party. Unlike most studies
[20-23] our survey didn’t show that health concern was
the primary reason for quitting smoking. Cost was the
first reported reason for having made the last quit
attempt or for a future attempt in our study. Dramatic
increases of cigarette taxes in France in 2003 and 2004
have probably boosted this reason to quit in the lead
position. Social pressure also ranked high in the reasons
to quit smoking, reported second for the last attempt
and forth for a future attempt. The idea of improving
physical fitness was the most reported reason to quit
smoking in the health concern category. Here again, this
result differs from what is usually reported [20-22].
Information campaigns were not considered as a signifi-
cant trigger of quit attempts in our study. Interestingly,
the report of smoking ban as a reason to quit doubled
when moving from last attempt to a future attempt.
This survey took place several months before the intro-
duction of the smoking ban in France (February 2007).
It seems that some smokers anticipated the ban as a
potential trigger for smoking cessation.
The relationship between reasons of relapse and
duration of attempts is of some interest. Craving and
some withdrawal symptoms (anxiety, irritability)
tended to trigger the relapse quickly. Other withdrawal
symptoms (weight gain and depression) triggered
relapse much later. Anxiety, irritability, and depression
are withdrawal symptoms that last 2-4 weeks [24]. In
our study, not only depression was rarely reported, but
it triggered relapse far later (median 12 months).
Weight gain is considered more as an offset symptom
[24], and indeed triggered delayed relapses in this
study (median 4 months). Post-cessation weight gain
was reported as a middle range barrier to smoking ces-
sation (33%). French smokers, and particularly female
smokers, are known to have a particularly high level of
weight concerns [25].
Table 4 Barriers to smoking cessation
Barriers to smoking cessation Yes
Smoking helps me control stress 62%
Without cigarettes, I would feel too irritable to be around 51%
Without cigarettes, I would feel too anxious or worried about
things
42%
I enjoy smoking too much to give it up 41%
It would be too hard to control my weight without smoking 33%
I don’t know how to go about quitting smoking 29%
There are too many difficult things going on in my life right now 28%
I can’t afford or find a smoking cessation program 28%
Smoking helps me control other behaviours that I have already
changed
17%
I have tried to quit smoking in the past so many times,
I’ve given up
14%
Without cigarettes, I would fell too down or sad 14%
My family and friends don’t think it is important to quit smoking 12%
Questionnaire adapted from [11]
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smokers didn’t use any form of smoking cessation medi-
cation during their last quit attempt. For those who
used some form of support, nicotine patch was the most
popular treatment. Price of treatment and treatment-
emergent adverse events were rarely reported as reasons
for relapse. It is noteworthy that, considering a future
attempt, more smokers intend to use smoking cessation
medications, even though 28% considered the price of a
smoking cessation program as a significant barrier to
smoking cessation.
Accordingly with the reported reasons for having
relapsed from the previous quit attempt, this repre-
sentative sample of smokers didn’t seem to consider
the risk of developing depression as a significant
barrier to smoking cessation. In contrast, the risk of
not controlling stress and of developing anxiety and
irritability were the leading barriers to smoking
cessation.
Finally, only 40% of smokers reported intending to
quit smoking definitively. This may seem a small num-
ber compared to other reports [6,30]. However, most
smokers declaring an intention to quit smoking, do not
intend to do so definitively [31].
This study had some limitations: the response rate was
66%, and older and retired people were over-repre-
sented. The weighting however corrected this bias to
some extent, since its efficacy was 76.5%. These sam-
pling biases are in the range of French competing sur-
veys [6,7].
Conclusions
The most sticking findings from the analysis of the first
wave of the FOCUS cohort are that smoking prevalence
was much lower than in previous reports. Smoking ces-
sation rates were also reduced. Reasons for these differ-
ences were unclear. Cost and social pressure were the
main reasons for quitting smoking, maybe an effect of
dramatic tax increases and smoking ban. Depression
was not considered as a significant trigger for relapse or
barrier to quit smoking.
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